Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Ovarian Neoplasms

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 39 articles: HTML format

Single Articles

July 2008
1. SONNEMANN J , Huls I, Sigler M, Palani CD, et al
   Histone deacetylase inhibitors and aspirin interact synergistically to induce cell death in ovarian cancer cells.
   Oncol Rep. 2008;20:219-24.
   PubMed     Related articles    Abstract available
   
   
   May 2008
2. OBAYASHI Y , Yabushita H, Kanyama K, Noguchi M, et al
   Role of serum-derived hyaluronan-associated protein-hyaluronan complex in ovarian cancer.
   Oncol Rep. 2008;19:1245-51.
   PubMed     Related articles    Abstract available
   
   
   
3. NAKAMURA K , Takamoto N, Hongo A, Kodama J, et al
   Secretory leukoprotease inhibitor inhibits cell growth through apoptotic pathway on ovarian cancer.
   Oncol Rep. 2008;19:1085-91.
   PubMed     Related articles    Abstract available
   
   
   March 2008
4. LATTRICH C , Juhasz-Boess I, Ortmann O, Treeck O, et al
   Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
   Oncol Rep. 2008;19:811-7.
   PubMed     Related articles    Abstract available
   
   
   
5. HUAN Z , Nakayama K, Nakayama N, Ishibashi M, et al
   Genetic classification of ovarian carcinoma based on microsatellite analysis: relationship to clinicopathological features and patient survival.
   Oncol Rep. 2008;19:775-81.
   PubMed     Related articles    Abstract available
   
   
   
6. YAMAGUCHI K , Mandai M, Fukuhara K, Higuchi T, et al
   Malignant transformation of mature cystic teratoma of the ovary including three cases occurring during follow-up period.
   Oncol Rep. 2008;19:705-11.
   PubMed     Related articles    Abstract available
   
   
   February 2008
7. MATSUMURA N , Mandai M, Hamanishi J, Yamaguchi K, et al
   Immunostimulatory effect of Fms-like tyrosine kinase 3 ligand on peripheral monocyte-derived dendritic cells and natural killer cells: Utilization for ovarian cancer treatment.
   Oncol Rep. 2008;19:505-15.
   PubMed     Related articles    Abstract available
   
   
   January 2008
8. RATAJSKA M , Brozek I, Senkus-Konefka E, Jassem J, et al
   BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
   Oncol Rep. 2008;19:263-8.
   PubMed     Related articles    Abstract available
   
   
   
9. BARBERA M , Caputo A, Zampiron A, Gobbi S, et al
   The ability of coumarin-, flavanon- and flavonol-analogues of flavone acetic acid to stimulate human monocytes.
   Oncol Rep. 2008;19:187-96.
   PubMed     Related articles    Abstract available
   
   
   
10. YASUDA M , Miyazawa M, Fujita M, Kajiwara H, et al
    Expression of hypoxia inducible factor-1alpha (HIF-1alpha) and glucose transporter-1 (GLUT-1) in ovarian adenocarcinomas: difference in hypoxic status depending on histological character.
    Oncol Rep. 2008;19:111-6.
    PubMed     Related articles    Abstract available
    
    
    December 2007
11. GRISARU D , Hauspy J, Prasad M, Albert M, et al
    Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings.
    Oncol Rep. 2007;18:1347-56.
    PubMed     Related articles    Abstract available
    
    
    November 2007
12. HOGDALL EV , Christensen L, Hogdall CK, Blaakaer J, et al
    Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: From the 'MALOVA' Ovarian Cancer Study.
    Oncol Rep. 2007;18:1051-9.
    PubMed     Related articles    Abstract available
    
    
    
13. SKIRNISDOTTIR I , Lindborg K, Sorbe B
    Adjuvant chemotherapy with carboplatin and taxane compared with single drug carboplatin in early stage epithelial ovarian carcinoma.
    Oncol Rep. 2007;18:1249-56.
    PubMed     Related articles    Abstract available
    
    
    October 2007
14. SHIGETO T , Yokoyama Y, Xin B, Mizunuma H, et al
    Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
    Oncol Rep. 2007;18:833-40.
    PubMed     Related articles    Abstract available
    
    
    
15. THOENNISSEN NH , Schliemann C, Brunnberg U, Schmidt E, et al
    Chemotherapy in metastatic malignant triton tumor: report on two cases.
    Oncol Rep. 2007;18:763-7.
    PubMed     Related articles    Abstract available
    
    
    August 2007
16. DI CARLO A , Mariano A, Terracciano D, Mazzarella C, et al
    Gelatinolytic activities (matrix metalloproteinase-2 and -9) and soluble extracellular domain of Her-2/neu in pleural effusions.
    Oncol Rep. 2007;18:425-31.
    PubMed     Related articles    Abstract available
    
    
    
17. TSUKIOKA M , Matsumoto Y, Noriyuki M, Yoshida C, et al
    Expression of glucose transporters in epithelial ovarian carcinoma: correlation with clinical characteristics and tumor angiogenesis.
    Oncol Rep. 2007;18:361-7.
    PubMed     Related articles    Abstract available
    
    
    July 2007
18. ISONISHI S , Saitou M, Saitou M, Yasuda M, et al
    Differential regulation of the cytotoxicity activity of paclitaxel by orobol and platelet derived growth factor in human ovarian carcinoma cells.
    Oncol Rep. 2007;18:195-201.
    PubMed     Related articles    Abstract available
    
    
    
19. DE SOUSA DAMIAO R , Fujiyama Oshima CT, Stavale JN, Goncalves WJ, et al
    Analysis of the expression of estrogen receptor, progesterone receptor and chicken ovalbumin upstream promoter-transcription factor I in ovarian epithelial cancers and normal ovaries.
    Oncol Rep. 2007;18:25-32.
    PubMed     Related articles    Abstract available
    
    
    June 2007
20. TAKAO M , Okamoto A, Nikaido T, Urashima M, et al
    Increased synthesis of indoleamine-2,3-dioxygenase protein is positively associated with impaired survival in patients with serous-type, but not with other types of, ovarian cancer.
    Oncol Rep. 2007;17:1333-9.
    PubMed     Related articles    Abstract available
    
    
    May 2007
21. YAN XD , Li M, Yuan Y, Mao N, et al
    Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Oncol Rep. 2007;17:1163-9.
    PubMed     Related articles    Abstract available
    
    
    
22. STEFFEN AC , Almqvist Y, Chyan MK, Lundqvist H, et al
    Biodistribution of 211At labeled HER-2 binding affibody molecules in mice.
    Oncol Rep. 2007;17:1141-7.
    PubMed     Related articles    Abstract available
    
    
    March 2007
23. SONODA K , Miyamoto S, Yotsumoto F, Yagi H, et al
    Clinical significance of RCAS1 as a biomarker of ovarian cancer.
    Oncol Rep. 2007;17:623-8.
    PubMed     Related articles    Abstract available
    
    
    
24. MATERNA V , Surowiak P, Markwitz E, Spaczynski M, et al
    Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients.
    Oncol Rep. 2007;17:505-16.
    PubMed     Related articles    Abstract available
    
    
    February 2007
25. LI HW , Leung SW, Chan CS, Yu MM, et al
    Expression of maspin in endometrioid adenocarcinoma of endometrium.
    Oncol Rep. 2007;17:393-8.
    PubMed     Related articles    Abstract available
    
    
    
26. MIYANISHI M , Mandai M, Matsumura N, Yamaguchi K, et al
    Immortalized ovarian surface epithelial cells acquire tumorigenicity by Acrogranin gene overexpression.
    Oncol Rep. 2007;17:329-33.
    PubMed     Related articles    Abstract available
    
    
    January 2007
27. XING H , Wang S, Weng D, Chen G, et al
    Knock-down of P-glycoprotein reverses taxol resistance in ovarian cancer multicellular spheroids.
    Oncol Rep. 2007;17:117-22.
    PubMed     Related articles    Abstract available
    
    
    
28. WORBS S , Shabani N, Mayr D, Gingelmaier A, et al
    Expression of the inhibin/activin subunits (-alpha, -betaA and -betaB) in normal and carcinogenic endometrial tissue: possible immunohistochemical differentiation markers.
    Oncol Rep. 2007;17:97-104.
    PubMed     Related articles    Abstract available
    
    
    December 2006
29. TAKANO M , Kikuchi Y, Yaegashi N, Suzuki M, et al
    Adjuvant chemotherapy with irinotecan hydrochloride and cisplatin for clear cell carcinoma of the ovary.
    Oncol Rep. 2006;16:1301-6.
    PubMed     Related articles    Abstract available
    
    
    November 2006
30. KAWAUCHI S , Yamamoto Y, Uchida K, Chochi Y, et al
    Significance of cyclin E and p27 expression in malignant ovarian germ cell tumors: correlation with the cell proliferation activity and clinicopathologic features.
    Oncol Rep. 2006;16:1029-33.
    PubMed     Related articles    Abstract available
    
    
    
31. HIRAMA M , Isonishi S, Yasuda M, Ishikawa H, et al
    Characterization of mitochondria in cisplatin-resistant human ovarian carcinoma cells.
    Oncol Rep. 2006;16:997-1002.
    PubMed     Related articles    Abstract available
    
    
    August 2006
32. MABUCHI Y , Yamoto M, Minami S, Umesaki N, et al
    The autocrine effect of activin A on human ovarian clear cell adenocarcinoma cells.
    Oncol Rep. 2006;16:373-9.
    PubMed     Related articles    Abstract available
    
    
    
33. DEVOUASSOUX-SHISHEBORAN M , Deschildre C, Mauduit C, Berger G, et al
    Expression of galectin-3 in gonads and gonadal sex cord stromal and germ cell tumors.
    Oncol Rep. 2006;16:335-40.
    PubMed     Related articles    Abstract available
    
    
    May 2006
34. GOTO T , Takano M, Sakamoto M, Kondo A, et al
    Gene expression profiles with cDNA microarray reveal RhoGDI as a predictive marker for paclitaxel resistance in ovarian cancers.
    Oncol Rep. 2006;15:1265-71.
    PubMed     Related articles    Abstract available
    
    
    
35. WOENCKHAUS J , Franke FE, Hackethal A, Von Georgi R, et al
    Glucocorticosteroid receptors in ovarian carcinomas.
    Oncol Rep. 2006;15:1137-40.
    PubMed     Related articles    Abstract available
    
    
    April 2006
36. SUI L , Dong Y, Watanabe Y, Yamaguchi F, et al
    Alteration and clinical relevance of PTEN expression and its correlation with survivin expression in epithelial ovarian tumors.
    Oncol Rep. 2006;15:773-8.
    PubMed     Related articles    Abstract available
    
    
    
37. SUI L , Dong Y, Watanabe Y, Yamaguchi F, et al
    Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
    Oncol Rep. 2006;15:765-71.
    PubMed     Related articles    Abstract available
    
    
    March 2006
38. KIM TJ , Lee KM, Choi CH, Lee JW, et al
    Germline mutations of BRCA1 in two Korean hereditary breast/ovarian cancer families.
    Oncol Rep. 2006;15:565-9.
    PubMed     Related articles    Abstract available
    
    
    February 2006
39. MABUCHI Y , Yamoto M, Minami S, Umesaki N, et al
    Immunohistochemical localization of inhibin and activin subunits, activin receptors, and Smads in ovarian clear cell adenocarcinoma.
    Oncol Rep. 2006;15:291-6.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: